Expansion of antibody reactivity in the cerebrospinal fluid of multiple sclerosis patients – follow-up and clinical implications
<p>Abstract</p> <p>Background</p> <p>An intrathecal polyspecific antibody response is a well known finding in multiple sclerosis. However, little is known about the evolution of intrathecal antibodies over time and their impact on the disease progress. Therefore, we foc...
Main Authors: | Reske Dirk, Petereit Hela-Felicitas |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2005-06-01
|
Series: | Cerebrospinal Fluid Research |
Online Access: | http://www.cerebrospinalfluidresearch.com/content/2/1/3 |
Similar Items
-
The Cerebrospinal Fluid in Multiple Sclerosis
by: Florian Deisenhammer, et al.
Published: (2019-04-01) -
Cerebrospinal fluid in multiple sclerosis
by: Rammohan Kottil
Published: (2009-01-01) -
Multiple Sclerosis Cerebrospinal Fluid Biomarkers
by: Gavin Giovannoni
Published: (2006-01-01) -
Cerebrospinal fluid biomarkers in multiple sclerosis
by: Hayrettin Tumani, et al.
Published: (2009-08-01) -
Comparison of DNA-hydrolyzing antibodies from the cerebrospinal fluid and serum of patients with multiple sclerosis.
by: Taisiya A Parkhomenko, et al.
Published: (2014-01-01)